(Reuters) -Alkermes said on Wednesday it will acquire Avadel Pharmaceuticals for up to $2.1 billion gaining access to the company’s approved excessive daytime sleepiness drug.
(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
Alkermes to acquire Avadel for up to $2.1 billion
Oct 22, 2025 | 6:11 AM
Current Weather
7-Day Forecast ยป
Tue May 19
Evansville, IN, USA
68°FPartly Cloudy
Now Playing
WABX 107.5 | Evansville's Classic Rock Station
Comments